Annovis Bio Statistics
NYSE: ANVSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.15-0.065 (-5.37%)
Market open · Delayed 15 min · as of Oct 8, 12:13 PM ET
Annovis Bio by the numbers
Annovis Bio has a market capitalization of $48.9 million based on 42.68M shares outstanding. With trailing EPS of $-1.75, Annovis Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 24.7% below its 50-day average and 46.4% below its 200-day average.
Average daily trading volume is 888.45K shares, or about $1.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ANVS valuation vs. peer median
| Metric | ANVS | Peer median | Difference |
|---|---|---|---|
| Market cap | $48.87M | $50.86M | -4% |
| Avg. volume | 888.45K | 208.97K | +325% |
Peer median across 8 companies: SER, EDSA, ZYBT, HYPD, DWTX, ACET, CRVO, TLPH.
Valuation
- Market cap
- $48.87M
- EPS (TTM)
- $-1.75
- Shares outstanding
- 42.68M
Price and trading
- Previous close
- 1.21
- Open
- 1.21
- Day range
- 1.14 – 1.21
- 52-week range
- 1.04 – 5.50
- 52-week change
- -46.46%
- Beta
- —
- Volume
- 269.79K
- Average volume
- 888.45K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2025
Additional statistics
- Market Cap
- 48.87M
- Forward Pe
- -1.33
- Eps
- -1.75
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.50
- Week52 Low
- 1.04
- Avg Volume
- 888.45K
- Shares Outstanding
- 42.68M
- Ma50
- 1.52
- Ma200
- 2.13
- Earnings Date
- Aug 12, 2025
- Pct From52w High
- -79.18%
- Pct From52w Low
- 10.10%